News Releases

News Releases

Metacrine to Present at Jefferies 2019 Global Healthcare Conference
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Ken Song, M.D., President and CEO, will present at the
May 21, 2019
Metacrine Completes $65 Million Series C Financing
Proceeds will support clinical development of FXR program in NASH and GI diseases SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced it has
Jun 6, 2018
Displaying 11 - 20 of 30